Microbial metabolism of danazol (17α-pregna-2,4-dien-20-yno[2,3-d]isoxazol-17β -ol) by Beauveria bassiana ATCC 7159 and Glyocladium viride ATCC 10097 afforded four metabolites. The isolated metabolites were identified by different spectroscopic techniques as 6β -hydroxy danazol, which is a not yet reported danazol metabolite, 17β -hydroxy-17α-pregn-4-en-20-yn-3-one (ethisterone) and 17β -hydroxy-2α-(hydroxymethyl)-17α-pregn-4-en-20-yn-3-one (2α-hydroxymethyl ethisterone), which represent the major danazol metabolites detected in human urine. The last metabolite, 6β ,17β -dihydroxy-2-(hydroxymethyl)-17α-pregna-1,4-dien-20-yn-3-one, is also a minor human metabolite, for which the NMR data are described here for the first time. The metabolites were isolated in quantities that allowed their use for direct comparison in routine doping analysis.
Introduction

Danazol
isoxazol-17β -ol) is a synthetic derivative of ethisterone that is used in the treatment of a wide variety of medical conditions, mainly endometriosis and benign fibrocystic mastitis (Barbieri and Ryan, 1981; De Oca Porto et al., 2006) . It has also been reported that danazol, as an attenuated androgen, may have some efficacy in increasing the platelet count of patients with myelodysplastic syndrome (Chan et al., 2002) . Beyond its medical uses, danazol is classified as class S1 anabolic agent in the list of forbidden substances in sports by the World Antidoping Agency (WADA) because danazol is structurally related to the anabolic steroid stanozolol (De Boer et al., 1992) . In fact, some anabolic effect attributed to danazol itself has been reported (Choi and Chung, 1998) . Like most steroids, danazol is extensively biotransformed, and several metabolites have been reported in human urine and serum (Potts, 1977; Rosi et al., 1977; Haning et al., 1982) . Identification of anabolic steroids in sports laboratories depends mostly on gas chromatography/mass spectrometry (GC-MS) and liquid chromatography/mass spectrometry (LC-MS) analyses. Nevertheless, many of these metabolites have remained unknown despite the availability of a large body of data. Thus, the solution for more confident detection would be the isolation, in large quantities, and proper identification of the metabolites through full structure elucidation by NMR spectroscopy for their use as reference standards in forensic analysis by GC-MS or LC-MS. Determining factors in the applicability of this approach to human biological samples are the low magnitude and the short life-time of many of these metabolites in human urine and serum, as well as the complexity of analysis due to high concentrations of endogenous compounds. In this work, we used microbial transformation by whole cells as a model to mimic the human metabolism of danazol for large-scale isolation and full structure elucidation of its metabolites. Microbial transformation provides many advantages over other systems adopted for metabolic studies such as chemical derivatization (Kieslich, 1976; Clark et al., 1989) , in vitro incubation with cellular or subcellular (microsomal) systems (reviewed in Levesque et al., 2002) , or the use of chimeric mice with humanized liver (Lootens et al., 2009 ). These advantages include high catalytic activity and high regio-and stereospecificity, easier handling not requiring specific culture conditions, as well as higher economy and versatility. Steroids are readily transformed by microbes, as documented by many studies (Hanson et al., 1996; Wilson et al., 1999; Choudhary et al., 2005) . In this study, four major microbial metabolites of danazol were obtained and identified by different spectroscopic means, among other several minor ones.
Results and Discussion
Screening for danazol biotransformation using 23 microorganisms revealed that Beauveria bassiana ATCC 7159 and Glyocladium viride ATCC 10097 gave best results.
The ethyl acetate extracts from the culture medium and the whole cells of the two organisms after danazol biotransformation gave several spots on thin-layer chromatography (TLC) plates. Scaling up the reaction resulted in the isolation and identification of four major metabolites, 2 -5 (Fig. 1) . Two of these metabolites, identified as ethisterone (3) and 2α-hydroxymethyl ethisterone (4), are known major human metabolites of danazol (Davison et al., 1976; Potts, 1977; Rosi et al., 1977; Rose et al., 1988; Murakami et al., 1993) . Metabolite 2, 6β -hydroxy danazol, is a new, hitherto unidentified metabolite. 6β -Hydroxy derivatives are important metabolites in the detection of positive cases of steroid abuse that made their synthesis necessary (reviewed in Schänzer et al., 1995) . Moreover, a previous metabolic study on human cytochrome P450 2J2 reported the detection of hydroxylated derivatives of danazol based on molecular ion peaks in LC-MS/MS spectra, but exact structures could not be assigned to these ions (Lee et al., 2010) . Metabolite 2 Fig. 1 . Chemical structure of danazol (1) and its metabolites 2 -5.
could possibly be another minor human metabolite of danazol that has not yet been identified. Metabolite 5, 6β ,17β -dihydroxy-2-(hydroxymethyl)-17α-pregna-1,4-dien-20-yn-3-one, is also a minor danazol human metabolite that was tentatively identified in human urine by Rosi et al. (1977) and De Oca Porto et al. (2006) . Its structure was also hypothesized by Kim et al. (2001) , based on GC-MS data for danazol metabolites in equine urine. The full NMR data of this metabolite are presented here for the first time. Danazol metabolites in this study were isolated by column chromatography (CC) in quantities sufficient for their identification through NMR spectroscopy and mass spectrometry which allowed proper structure elucidation. They were obtained in a simple single-step bioconversion process, compared to the elaborative and multi-step procedure of Rosi et al. (1977) , which comprised chemical and microbiological conversions of several substrates and utilized a number of different organisms for the preparation of each metabolite of danazol. This illustrates the importance of the selection of suitable microorganisms in a screening step (see Experimental) .
The isolated metabolites were identified as follows: Metabolite 2 gave a pseudomolecular ion peak at (calcd. 353.1991) , indicating a molecular formula of C 22 H 27 NO 3 . Hydroxylation was confirmed by the appearance of a new methine carbinol proton at δ H 4.24 ppm (1H, br s) in its 1 H NMR spectrum (Table I) . This proton was correlated by HMQC to a carbon resonance at δ C 70.5 ppm which was assigned to position 6 by an HMBC experiment (Fig. 2 ). H-6 showed 3 J correlations to C-4 and C-10 (δ C 112.4 and 40.0 ppm, showed cross-peaks with each of C-6 and C-10. Hydroxylation at position 6 was further confirmed by a downfield shift of H-19 by 0.14 ppm (Table I) and by β -and γ-effects on carbon atoms in the vicinity of C-6. The β -effect was evidenced by deshielding of C-7 (δ C 37.9 ppm) by 7.0 ppm, while the γ-effect was evidenced by shielding of C-8 (δ C 30.7 ppm) by 6.1 ppm compared to danazol (1) ( Table II) (Hanson et al., 1996; Swizdor and Kolek, 2005) . β -Orientation of the 6-hydroxy group was assigned based on the width at half height of H-6 (W 1/2 = 7.4 Hz) (Choudhary et al., 2005) . Other signals in the 1 H and 13 C NMR spectra of metabolite 2 confirmed that the isoxazole ring is still intact. Proton H-2 appeared at the same position in the substrate (δ H 8.25 ppm, s and 8.28 ppm, s, respectively, Table I ) and showed 2 J and 3 J correlations to carbon signals at δ C 109.9 and 164.3 ppm (C-2 and C-3, respectively). Similarly, the carbon signals of the corresponding positions in the isoxazole ring of danazol (1) and its metabolite 2 exhibited comparable shifts, viz., positions 2, 3, and 2 (Table II) . These data collectively confirmed the structure of 2 as 6β -hydroxy danazol ( Fig. 1) , which is a new danazol metabolite. All other danazol metabolites obtained by scaling up the reaction with G. viride ATCC 10097 showed cleavage of the isoxazole ring as follows:
Metabolite 3 showed a pseudomolecular ion peak at m/z 313 ([M + + H]) in the ESI mass spectrum (positive ion mode) indicating a molecular formula of C 21 H 28 O 2 . NMR spectral data revealed disappearance of the hallmarks of the isoxazole ring. The characteristic signal due to H-2 (singlet at δ H 8.28 ppm) was absent from the 1 H NMR spectrum, also both H-1 protons appeared as multiplets at δ H 1.43 and 2.00 ppm instead of the characteristic doublets with large coupling constant (J = 16.0 Hz) of the corresponding position in danazol (δ H 2.44 and 2.67 ppm) ( Table I ). The three olefinic resonances characteristic of positions 2, 3, and 2 of the isoxazole ring in danazol (1) were also absent from the 13 C NMR spectrum of 2 (Table II). Instead, new olefinic resonances appeared at δ C 122.4 and 171.4 ppm together with a ketonic group at δ C 207.5 ppm. These resonances could be assigned to carbon atoms 4, 5, and 3, respectively. These data char- acterized metabolite 3 as a ∆4 C 21 steroid with a keto group at position 3. Since the substituents at position 17 remained unchanged in this metabolite as well as in the other metabolites, as can be seen from the spectral data in Tables I and II, the structure of metabolite 3 could be deduced as ethisterone or 17β -hydroxy-17α-pregn-4-en-20-yn-3-one (Fig. 1) . The 13 C NMR data were found comparable to those published for ethisterone (Rodriguez-Molina et al., 2010) . Ethisterone is known to be the major human metabolite of danazol (Davison et al., 1976; Potts, 1977; Rosi et al., 1977; Haning et al., 1982) .
Metabolite 4 showed a pseudomolecular ion peak in the ESI mass spectrum (positive ion mode) at m/z 343 ([M + + H]) indicating a molecular formula of C 22 H 30 O 3 . Its 13 C NMR spectrum (Table II) showed the appearance of a ketonic carbon signal at δ C 199.2 ppm. This carbon resonance was assigned to position 3 by HMBC (Fig. 2) , where H-1 a and H-1 b (δ H 1.24 ppm, m and 1.81 ppm, m) showed 3 J correlation to this carbon atom. Its 1 H NMR spectrum (Table I) showed also the absence of the isoxazole proton (H-2 ), a singlet at δ H 8.28 ppm in 1, and the appear- ance of downfield methylene proton signals at δ H 3.47 (1H, ddd, J = 16.9, 11.5, and 5.3 Hz) and 3.66 ppm (1H, ddd, J = 15.3, 9.9, and 5.3 Hz) which were correlated by HMQC to a carbon resonance at δ C 60.5 ppm. This indicated the presence of a hydroxymethyl functionality. The hydroxymethyl group was assigned by an HMBC experiment (Fig. 2) to position 2, where the methylene protons showed 3 J correlation to C-3 (δ C 199.2 ppm) and C-1 (δ C 39.4 ppm). Running the spectra in DMSO-d 6 allowed observation of signals due to protons of OH groups at C-2 (δ H 4.42 ppm, t, J = 5.3 Hz) and C-17 (δ H 5.30 ppm, s), respectively. In the HMBC experiment (Fig. 2) , the proton of the C-2 OH group showed also cross-peaks with signals due to C-1 (δ C 39.4 ppm) and C-3 (δ C 199.2 ppm). Other correlations were observed between H-4 (δ H 5.57 ppm, s) and each of C-2 (δ C 44.4 ppm), C-5 (δ C 170.9 ppm), and C-10 (δ C 39.0 ppm). The NMR data of metabolite 4 were found comparable to those published by Choudhary et al. (2002) , which confirmed the structure of this metabolite as 2-hydroxymethyl ethisterone or 17β -hydroxy-2α-(hydroxymethyl)-17α-pregn-4-en-20-yn-3-one (Fig. 1 ). This metabolite was identified previously in human urine as a major danazol metabolite (Davison et al., 1976; Potts, 1977; Rosi et al., 1977) . It was also obtained as a microbial metabolite of danazol upon biotransformation by Aspergillus niger, Bacillus cereus, Cephalosporium aphidicola and Fusarium lini (Choudhary et al., 2002) , and biotransformation by Fusarium solani and Gibberella fujikuorii (Azizuddin and Choudhary 2010) . The 1 H NMR spectrum of metabolite 5 (Table I ) also showed the absence of a signal due to H-2 (δ H 8.28 ppm, s) in danazol. Similarly to metabolite 4, it showed the presence of hydroxymethyl protons at C-2 , but in this case they appeared as a pair of doublets with a J value of 10.8 Hz (signals at δ H 3.22 and 3.37 ppm), instead of the pair of ddd at δ H 3.47 and 3.66 ppm in metabolite 4. This indicated absence of the C-2 proton, probably due to reductive cleavage of the isoxazole ring. Formation of a new double bond at C-1 was confirmed by the appearance of a new signal due to an olefinic proton singlet in the 1 H NMR spectrum (Table I ) at δ H 6.80 ppm, assigned to H-1, as well as the presence of two new olefinic resonances in the 13 C NMR spectrum of 5 at δ C 151.0 and 136.5 ppm compared to 4 (Table II) . These resonances were assigned by HMBC (Fig. 2) to positions 1 and 2, respectively, where 2 J correlations were observed between H-1 (δ H 6.80 ppm, s) and each of C-2 and C-10 (δ C 136.5 and 43.5 ppm), while it showed 3 J correlations with C-3, C-5, and C-19 (δ C 185.8, 171.1, and 19.0 ppm, respectively) . These data suggested an 1,2-dehydro derivative of 4. A new methine carbinol proton signal in the 1 H NMR spectrum of 5 at δ H 4.32 ppm (br s) suggested hydroxylation of this derivative. This proton was correlated by HMQC to the carbon resonance at δ C 70.1 ppm. The assignment of this carbon resonance to position 6 was confirmed by the observation of β -and γ-effects on chemical shifts of carbon atoms in its vicinity as well as by HMBC. The β -effect was evident by deshielding of C-7 (δ C 35.8 ppm) by 4.9 ppm, while the γ-effect caused shielding of C-8 (δ C 32.0 ppm) by 4.8 ppm, compared to danazol (Table II ). In the HMBC experiment (Fig. 2) , H-6 (δ H 4.32 ppm, br s) showed cross-peaks with each of C-4 and C-10 (δ C 128.0 and 43.5 ppm). Correspondingly, H-4 (δ H 5.94 ppm, s) showed 3 J correlation to C-6 (δ C 70.1 ppm) and C-10 (δ C 43.5 ppm). H-6 was assigned an α (equatorial)-orientation based on width at half height (W 1/2 = 7.4 Hz) (Choudhary et al., 2005) . The C-6 hydroxy group must therefore have a β (axial)-orientation. These data collectively identified 5 as 6β ,17β -dihydroxy-2-(hydroxymethyl)-17α-pregna-1,4-dien-20-yn-3-one (Fig. 1) . The structure of this compound was hypothesized previously based only on GC-MS data obtained for danazol metabolites in equine and human urine samples, respectively (Kim et al., 2001; De Oca Porto et al., 2006) . The NMR data are presented here for the first time.
In conclusion, this work demonstrates the capacity of microorganisms to mimic mammalian drug metabolism. In case of danazol, four microbial metabolites could be isolated and their structures fully elucidated. Three of the isolated metabolites are also known human metabolites of danazol. Thus, the purified and identified compounds can be further used as standards for direct comparison in routine analyses of anabolic steroids by GC-MS and LC-MS in urine and blood samples, in which these metabolites are usually present in trace amounts.
Experimental
General experimental procedures
1 H, 13 C NMR, HMBC, and HMQC spectra were obtained with a JEOL JNM-ECA500 spectrometer (JEOL Instruments, Tokyo, Japan), operating at 500 MHz ( 1 H) and 125 MHz ( 13 C); δ values are expressed in ppm. Mass spectrometry electrospray ionization (ESI-MS) spectra were carried out on a VG-ZAB-HF reversed-geometry mass spectrometer (VG Analytical, Waltham, MA, USA). FAB mass spectra were taken on a JEOL JMS600 mass spectrometer (JEOL Instruments). Column chromatography (CC) was performed on silica gel (70 -230 mesh; Merck, Darmstadt, Germany). Thin-layer chromatography (TLC) was carried out on precoated silica gel 60 GF 254 plates (Fluka, Darmstadt, Germany). Developed chromatograms were visualized by spraying with 0.01 % vanillin/H 2 SO 4 , followed by heating until maximum development of spot colour, or spraying with modified Dragendorff's reagent. Preparativescale TLC was carried out on 1 mm thick silica gel plates. Solvents were of reagent grade.
Substrate
Danazol (1) was extracted from Danol capsules (Winthorp, Sheffield, England) using CH 2 Cl 2 , and crystallized from the same solvent. Its identity was confirmed by comparison of its spectroscopic data with those in the literature (Choudhary et al., 2002) .
Fermentation method
Fermentation in liquid cultures was carried out according to the standard two-stage fermentation protocol of Betts et al. (1974) Each culture was used separately to inoculate 100-ml flasks containing 20 ml of the following media: 2 % glucose, 0.5 % soybean meal, 0.5 % yeast extract, 0.5 % NaCl, 0.5 % K 2 HPO 4 . The pH value was adjusted to 7.0 before autoclaving for 20 min at 121 • C. The inoculated flasks were incubated at 27 • C and 250 rpm for 72 h (stage I cultures) before being used to inoculate stage II culture flasks, in which 10 % inoculum volumes of stage I were used to inoculate another batch of sterile medium, and were incubated under the same conditions for 24 h. Danazol (30 mg) dissolved in 1.5 ml of CH 2 Cl 2 /DMSO (1:1, v/v) was added to the 24-h-old stage II cultures in 50-µl aliquots to give a final content of 1 mg substrate per flask. The flasks were incubated again and sampled periodically for analysis.
Sampling
Samples of 1 ml were taken after 12, 24, 36, and 48 h and then every other day for 2 weeks following substrate addition. Each sample was extracted by shaking three times with 0.5 ml of EtOAc and spun at 3000 × g for 1 min in a desktop centrifuge. The upper layer was pipetted off, and the extracts were concentrated and spotted on silica gel 60 GF 254 TLC plates and developed with CH 2 Cl 2 /MeOH (95:5). The developed chromatograms were visualized by spraying with vanillin/H 2 SO 4 , followed by heating on a hot plate until maximum development of the spot colour.
Preparative-scale conversion
Danazol (1 g each) was added to stage II cultures of microorganisms which had given the best results in the screening, i.e. Beauveria bassiana ATCC 7159 and Glyocladium viride ATCC 10097, at a concentration of 1 mg per ml culture medium in 1-l flasks. After incubation for 2 weeks under the same conditions, the broth and the fungal mycelia were combined, homogenized in a blender, and exhaustively extracted with 3 × 1 l EtOAc. The combined extracts were dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure to yield 900 and 1250 mg of residue, respectively.
Isolation and purification of the metabolites
Isolation of danazol metabolites of B. bassiana ATCC 7159
The EtOAc extract (850 mg) was fractionated on a silica gel column (70 cm × 1.5 cm) eluted with mixtures of CH 2 Cl 2 and MeOH. Fractions eluted with 0.5 % MeOH in CH 2 Cl 2 (413 mg) afforded untransformed substrate (R f 0.52, CH 2 Cl 2 /MeOH, 95:5; and R f 0.66, petroleum ether/EtOAc, 60:40; positive with Dragendorff's reagent; orange pink on heating with vanillin/H 2 SO 4 spray reagent). Further fractions, also eluted with 0.5 % MeOH in CH 2 Cl 2 (157 mg), contained mainly one major spot, which was purified by rechromatography on a silica gel column (50 cm × 1.0 cm) using mixtures of EtOAc in petroleum ether. Fractions eluted with 30 % EtOAc yielded metabolite 2 as yellowish needles (55 mg; R f 0.30, CH 2 Cl 2 /MeOH, 95:5; and R f 0.28, petroleum ether/EtOAc, 60:40; positive with Dragendorff's reagent; blue violet on heating with vanillin/H 2 SO 4 spray reagent).
Isolation of danazol metabolites of G. viride ATCC 10097
The EtOAc extract (1200 mg) was fractionated on a silica gel column (80 cm × 1.5 cm) and eluted with mixtures of petroleum ether and EtOAc. Fractions eluted with 20 % EtOAc in petroleum ether (570 mg) contained unchanged substrate (see above). Fractions eluted with 30 % EtOAc in petroleum ether (45 mg) contained one major spot along with several minor spots. Purification by rechromatography using the same solvent system yielded metabolite 3 as amorphous solid (3 mg; R f 0.51, CH 2 Cl 2 /MeOH, 95:5; and R f 0.30, petroleum ether/EtOAc, 65:35; negative with Dragendorff's reagent; pinkish-violet on heating with vanillin/H 2 SO 4 spray reagent). Fractions eluted with 35 % EtOAc in petroleum ether (71 mg) contained mainly one spot. Crystallization from CH 2 Cl 2 afforded metabolite 4 as colourless needles (55 mg; R f 0.40, CH 2 Cl 2 /MeOH, 95:5; and R f 0.21, petroleum ether/EtOAc, 65:35; negative with Dragendorff's reagent; blue violet on heating with vanillin/H 2 SO 4 spray reagent). Fractions eluted with 40 % EtOAc in petroleum ether (31 mg) contained a mixture of three spots. Purification on preparative TLC plates using petroleum ether/EtOAc (70:30) afforded metabolite 5 as amorphous solid (5 mg; R f 0.37, CH 2 Cl 2 /MeOH, 95:5; and R f 0.20, petroleum ether/EtOAc, 60:40; negative with Dragendorff's reagent; blue violet on heating with vanillin/H 2 SO 4 spray reagent).
